AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01286376 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Symbiotic Lactofos
Description: Lactobacillus Paracasei Lactobacillus Rhamnosus Lactobacillus Acidophilus Bifidobacterium lactis 12g/day
Study NCT01286376 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Maltodextrin
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Double Placebo
Description: 1 capsule daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole 15, placebo
Description: 15 mg Aripiprazole daily plus placebo daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole 7.5, Placebo
Description: Aripiprazole 7.5 mg daily plus Placebo daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 100, Placebo
Description: Topiramate 100 mg daily plus Placebo daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 200, Placebo
Description: Topiramate 200 mg daily plus Placebo daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 100, Aripiprazole 15
Description: Topiramate 100 mg daily plus Aripiprazole 15mg daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 100, Aripiprazole 7.5
Description: Topiramate 100 mg daily plus Aripiprazole 7.5mg daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 100, Aripiprazole 15mg
Description: Topiramate 100 mg daily plus Aripiprazole 15mg daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 200, Aripiprazole 7.5mg
Description: Topiramate 200 mg daily plus Aripiprazole 7.5mg daily
Study NCT00884884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 200, Aripiprazole 15
Description: Topiramate 200mg daily plus Aripiprazole 15mg daily
Study NCT01568021 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No intervention was administered in this study.
Study NCT04160000 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Catheter ablation
Description: Delivery of physical energy from external energy source via percutaneously inserted electrophysiologic catheter to destroy heart tissue in the human atrium and adjoining vasculature
Study NCT04160000 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rate or Rhythm control antiarrhythmic drugs for atrial fibrillation
Description: Administration of antiarrhythmic drug to achieve either rate control or restoration of sinus rhythm for management of atrial fibrillation
Study NCT04160000 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insertion of CardioMems Hemodynamic monitor
Description: Insertion of wireless hemodynamic monitor to provide hemodynamic data to guide heart failure therapy to achieve heart failure improvement.
Study NCT04160000 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empiric heart failure drug therapy
Description: Administration of heart failure drug therapy based on clinical evaluation to achieve heart failure improvement.
Study NCT01507753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omega-3 Supplementation
Description: The Ω3 group will receive 1000 mg Ω3 (two 500 mg capsules, each containing 350 mg EPA: 50 mg DHA; 100 other Ω3) two times daily for a total daily dose of 2000 mg Ω3 (1400 mg EPA: 200 mg DHA; 400 other Ω3). The placebo group will receive two capsules two times daily matched for odor and appearance with the active intervention.
Study NCT01507753 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducational Psychotherapy (PEP)
Description: Therapy sessions occur twice a week for up to 24 sessions of manualized treatment. The importance of separating symptoms from the individual is emphasized. The family is offered support, validation, and recognition for their own difficult experiences in living with the child's mood disorder. Family members are taught that patients are particularly vulnerable to stress and tension; thus, therapists work with families to reduce the level of stress and tension in their homes. Improvement of communication, problem solving and coping strategies can lead to restoration of hope for recovery and decrease family dysfunction. Goals include strengthening the parent-child bond and helping children and parents feel competent to manage depression now and in future recurrences.
Study NCT01507753 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo group will receive active monitoring (no IF-PEP) and two capsules two times daily matched for odor and appearance with the active intervention.
Study NCT00390936 — intervention group
Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: Brivanib
Description: Tablet, Oral, Brivanib 300 mg, 600 mg, 800 mg, 1000 mg, once daily (cycle 1: Day 1, Day 8 - 35), more than 5 weeks depending on response/toxicity
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Tumor tissue collection
Description: Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon.~Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis.~Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Sampling of ascites and pleural effusion
Description: Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darunavir (DRV) 800 milligram (MG) Oral Tablet
Description: 800 milligrams (mg) orally once daily for 96 weeks
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Darunavir (DRV) 800 milligram (MG) Oral Tablet
Description: 800 milligrams (mg) orally once daily for 96 weeks
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir 100 MG Oral Tablet
Description: 100 mg orally once daily for 96 weeks
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ritonavir 100 MG Oral Tablet
Description: 100 mg orally once daily for 96 weeks
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N(t)RTIs
Description: Choice of N(t)RTIs determined by clinician guided by either genotypic resistance testing or use of a protocol-specified algorithm for N(t)RTI selection
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 MG Oral Tablet
Description: 50 mg orally once daily for 96 weeks
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF 300 MG Oral Tablet
Description: 300 mg orally once daily for 96 weeks
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3TC 300 MG Oral Tablet
Description: 300 mg orally once daily for 96 weeks. Choice of 3TC or FTC will be determined by clinician
Study NCT03675815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FTC 200 MG Oral Cap
Description: 200 mg orally once daily for 96 weeks. Choice of emtricitabine or lamivudine will be determined by clinician
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Collecting urine samples
Description: Patient is asked to give a urine sample. Urine is collected in urine beaker.
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Collecting saliva sample
Description: Saliva sample is collected by spatula from the mouth cavity of the patient.
Study NCT04513626 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: DORAVIRINE 100 MG [Pifeltro]
Description: Immediate switch
Study NCT04513626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DORAVIRINE 100 MG [Pifeltro]
Description: Immediate switch
Study NCT01889199 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flutamide
Description: Flutamide 125 mg orally each 28 day cycle for 6 cycles
Study NCT01889199 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo orally each 28 day cycle for 6 cycles
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Collecting sputum
Description: Patient is asked to produce sputum into a 50ml lab tube.
Study NCT04221490 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Tricuspid Valve Replacement
Description: Replacement of the tricuspid valve through a transcatheter approach
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Collecting stool samples
Description: Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.
Study NCT01789229 — intervention group
Intervention type: OTHER
Intervention: Lavage/Irrigation
Description: Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.
Study NCT03159065 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bilberry
Description: Fruit beverage with bilberry and fermented oatmeal
Study NCT03159065 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blackcurrant
Description: Fruit beverage with blackcurrant and fermented oatmeal
Study NCT03159065 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mango
Description: Fruit beverage with mango and fermented oatmeal
Study NCT03159065 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beetroot
Description: Fruit beverage with beetroot and fermented oatmeal
Study NCT03159065 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rose hip
Description: Fruit beverage with rose hip and fermented oatmeal
Study NCT03159065 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Glucose drink
Description: A reference glucose drink
Study NCT00642499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronabinol
Description: 2.5 mg to 40 mg
Study NCT00642499 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT01199445 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Triple fortified extruded tice (Fe, Zn and vitamin A)
Description: Triple fortified extruded rice (Fe, Zn and vitamin A)will be mix at ratio of 1:50 with normal rice then give to children at school lunch meal for 60 days.
Study NCT01199445 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Triple fortified extruded tice (Fe, Zn and vitamin A)
Description: Triple fortified extruded rice (Fe, Zn and vitamin A)will be mix at ratio of 1:50 with normal rice then give to children at school lunch meal for 60 days.
Study NCT01497951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aminolaevulinic acid
Description: Photodynamic therapy
Study NCT01497951 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Methylcellulose Placebo
Description: Methylcellulose
Study NCT02177435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan
Study NCT02177435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telmisartan/Hydrochlorothiazide
Study NCT02177435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT03377179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABC294640
Description: Two 250 mg capsules of ABC294640 will be taken twice daily
Study NCT03377179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Sulfate 200 MG
Description: HCQ tablets will be taken at a dose that will be determined
Study NCT04266366 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Face-to-Face Rehabilitation program
Description: In each hospital, two trained therapists will carry out a face-to-face rehabilitation program consisting of electroanalgesia and an exercise program that follows the Mckenzie method. The physiotherapists place the electrodes in the patients, for this they use 5x9 cm electrodes, which they place at the bilateral paravertebral level, in the patients who present with radicular pain, the electrodes will be placed in the path of the affected nerve. The duration will be sufficient to carry out the Mckenzie protocol. Mckenzie exercises are designed to make changes in the internal periarticular components of the spine.
Study NCT04266366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine program
Description: It consists in an e-Health rehabilitation program through a web platform performing electroanalgesia and an exercise program following the Mckenzie method. Patients will be instructed in the use of the TENS device using 5x9cm electrodes at the bilateral paravertebral level, the patients that present radicular pain, the electrodes will be placed in the path of the affected nerve. The realization of exercises will be through the application of an Mckezie protocol. The duration will be the same as that used to carry out the Mckenzie protocol. Mckenzie exercises are designed to make changes in the internal components periarticular of the spine.
Study NCT04131699 — intervention group
Intervention type: DEVICE
Intervention: Cardiotronic ICON continuous non-invasive cardiac output monitor.
Description: cardiac index, cardiac output \& stroke volume measured and recorded with every change in intrathoracic pressure.
Study NCT04836234 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wrigley Extra Strawberry Flavour Sugar Free Chewing Gum
Description: Wrigley Extra Strawberry Flavour Sugar Free Chewing Gum 65g 40 pieces
Study NCT01693159 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ECA
Description: In the experimental arm patients will be topically treated with the liquid glue ethyl-2-cyanoacrylate (ECA).
Study NCT01693159 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard topical treatment of the institution, e.g. Lotio
Description: Standard treatment of the institution to treat painful cetuximab-induced rhagades
Study NCT02127983 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early intervention
Description: Training non-paid informal healthcare providers (such as store-keepers) in TB and HIV disease recognition, sputum specimen collection, referral to the public health system, and raising community awareness.~Front line public health personnel and community leaders were sensitised to support the intervention
Study NCT02127983 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Delayed intervention
Description: Delayed intervention arm, engaging informal providers Received the intervention after one year
Study NCT02270463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tagraxofusp-erzs
Description: Tagraxofusp-Erzs administered by IV infusion at doses of 7, 9, and 12 µg/kg/day
Study NCT01638533 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT06684067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient navigation
Description: Participants will receive online educational material, hospital site navigation guidance and direct contact with the patient navigator, in addition to standard instructions on the colonoscopy procedure.
Study NCT04102176 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stopping nucleos(t)ide therapy
Description: patients taking nucleoside(t)ide therapy will stop treatment
Study NCT04102176 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Continue nucleos(t)ide analogue
Description: Continue nucleos(t)ide analogue
Study NCT00411242 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: agomelatine
Study NCT00411242 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT02196688 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fruquintinib
Description: fruquintinib is a capsule in the form of 1mg and 5mg, orally, once daily, 3 weeks on/ 1 week off
Study NCT02196688 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo is a capsule in the form of 1mg and 5mg, orally, once daily, 3 weeks on/ 1 week off
Study NCT03636204 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AL001
Description: Active dose of AL001
Study NCT03636204 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline solution administered as a single infusion as palcebo.
Study NCT01355016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MDT-637
Description: Inhaled doses of MDT-637 over a 24 hour period
Study NCT01355016 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: MDT-637
Description: Inhaled doses of MDT-637 over a 24 hour period
Study NCT04674917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decompression + Hot pack, TENS, Mobilization, Exercise Therapy
Description: Group A which includes the acute group to study the effects of decompression we will apply the three main basic treatments along with decompression which is our main goal..~The basic treatments are~1. Hot Pack~2. TENSE~3. Mobilization ( on lumbar L1 toL5 ) Our first modality which is hot pack will be given to the patients for a duration of 15 minutes The next modality TENSE will be given for 10 minutes~The third treatment which is mobilization will be given 1 time on each joint of lumbar spine All these treatments must given in combination with the decompression.
Study NCT04674917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decompression + Hot pack , TENS , Mobilization , Exercise Therapy
Description: Group B which includes the chronic group to study the effects of decompression we will apply the three main basic treatments along with decompression which is our main goal..~The basic treatments are~1. Hot Pack~2. TENSE~3. Mobilization ( on lumbar L1 toL5 )~Our first modality which is hot pack will be given to the patients for a duration of 15 minutes The next modality TENSE will be given for 10 minutes~The third treatment which is mobilization will be given 1 time on each joint of lumbar spine All these treatments must given in combination with the decompression.
Study NCT04674917 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hot pack , TENS, Mobilization, Exercise therapy
Description: Group C which is our control group to compare it with the groups A and B to study the effects of decompression on lumbar radiculopathy The basic treatments are~1. Hot Pack~2. TENSE~3. Mobilization ( on lumbar L1 toL5 )~Our first modality which is hot pack will be given to the patients for a duration of 15 minutes The next modality TENSE will be given for 10 minutes~The third treatment which is mobilization will be given 1 time on each joint of lumbar spine It is kept in mind that in this group we will not apply the decompression along with the above treatments.
Study NCT02251106 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lumbar corset (Quickdraw, Aspen Medical Products)
Description: The corset (a.k.a. brace) is made of webbing and elastic. It is wrapped around the trunk and tightened with Velcro and a series of cords (like tying shoes).
Study NCT02251106 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar corset (Quickdraw, Aspen Medical Products)
Description: The corset (a.k.a. brace) is made of webbing and elastic. It is wrapped around the trunk and tightened with Velcro and a series of cords (like tying shoes).
Study NCT04875728 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefazolin
Description: Given IV
Study NCT04875728 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resection
Description: Undergo standard of care surgical resection
Study NCT01638533 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Romidepsin
Description: Given IV
Study NCT04875728 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo standard of care surgical resection
Study NCT00647387 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder)
Description: Device
Study NCT04259658 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Calcium electroporation
Description: Patients with cutaneous metastases will be treated with calcium electroporation.
Study NCT00685724 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Description: MET is a client-centered, directive form of therapy designed to enhance clients' intrinsic motivation to change.
Study NCT01516606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: clarithromycin, oral, high dose
Description: 2 g/day clarithromycin (once a day) for 14 days followed by 7 days interval to be repeated for 4 cycles in total
Study NCT03386305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EnvarsusXR
Description: Patients randomized to study drug will be converted to EnvarsusXR once daily.
Study NCT03386305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: Patients continue to take Tacrolimus BID, as a part of routine care.
Study NCT03273283 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Intervention
Description: Patient's received a brief intervention on alcohol use based on motivational techniques, and a referral to treatment when indicated.
Study NCT02203045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Total Knee Arthroplasty